Search

Elanco Animal Health Inc

Chiusa

SettoreSettore sanitario

25.09 2.79

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

23.99

Massimo

24.52

Metriche Chiave

By Trading Economics

Entrata

-3M

54M

Vendite

-3M

1.4B

P/E

Media del settore

372.714

57.371

EPS

0.34

Margine di Profitto

3.947

Dipendenti

9,400

EBITDA

-42M

274M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+28.3% upside

Dividendi

By Acuity

Utili prossimi

4 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.1B

12B

Apertura precedente

22.3

Chiusura precedente

25.09

Notizie sul Sentiment di mercato

By Acuity

37%

63%

128 / 340 Classifica in Healthcare

Elanco Animal Health Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 ago 2026, 19:36 UTC

Elanco Animal Health Inc. shares are trading higher during Monday's session, reaching a peak earlier in the day within its one-month trading range.

21 ago 2026, 23:46 UTC

Elanco Animal Health shares are higher in after-market trading, reflecting unusual activity despite no specific news to explain the movement.

20 ago 2026, 23:21 UTC

Elanco Animal Health Inc trades higher in after-market hours, despite broader market pressures from rising bond yields and geopolitical risks.

19 ago 2026, 20:06 UTC

Correlated Moves

Elanco Animal Health is gaining today, supported by a notable increase in the Forest Products sector, which has risen significantly during the session.

17 ago 2026, 19:26 UTC

Elanco Animal Health shares are lower today, trading flat since Friday's close. The stock remains below its 20-day moving average with no specific news driving the decline.

14 ago 2026, 23:36 UTC

Elanco Animal Health shares declined in after-market trading, remaining below the 20-day moving average amid concerns over a surprising drop in U.S. retail sales.

13 ago 2026, 20:06 UTC

Elanco Animal Health Inc shares are higher today amid a broader market uptrend. The stock remains below its 20-day moving average.

12 ago 2026, 19:51 UTC

Elanco Animal Health shares are declining today, despite high trading volume. No specific news was identified to explain the downward movement.

11 ago 2026, 19:36 UTC

News

Elanco Animal Health receives FDA Emergency Use Authorization for CLiK Extra wound spray to combat New World screwworm infestations, boosting shares during Tuesday's session.

10 ago 2026, 23:06 UTC

Elanco Animal Health shares are higher in after-market trading, following notable volatility during the session. The stock remains below its 20-day moving average.

7 ago 2026, 23:36 UTC

Elanco Animal Health shares are higher in after-market trading, following a session spike despite no specific company news identified.

6 ago 2026, 23:36 UTC

Elanco Animal Health Inc shares are higher in after-market hours. No specific news was identified to explain this movement, which shows routine trading.

5 ago 2026, 19:52 UTC

News

Elanco Animal Health reported second-quarter revenue of $1.368 billion and raised its full-year adjusted EPS guidance to between $1.10 and $1.16. Shares are higher.

4 ago 2026, 23:01 UTC

Elanco Animal Health Inc shares are higher in after-market hours, recovering from three days of declines amid broader market optimism and easing oil prices.

3 ago 2026, 20:02 UTC

Elanco Animal Health is trading lower amid a broader market decline, reflecting negative sentiment in the pharmaceuticals sector. No specific news was identified.

31 lug 2026, 23:01 UTC

Elanco Animal Health Inc shares are lower in after-market hours, trading near the lower end of their one-month range with no specific news identified.

30 lug 2026, 16:11 UTC

Elanco Animal Health is lower today, influenced by declines in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

29 lug 2026, 18:14 UTC

Elanco Animal Health shares are higher today, breaking a pattern of recent daily closes. No specific news was identified to explain the movement.

28 lug 2026, 18:26 UTC

Correlated Moves
News

Bank of America maintains its buy rating on Elanco Animal Health, citing a favorable catalyst profile ahead of second-quarter earnings. Shares are higher today.

27 lug 2026, 18:36 UTC

Elanco Animal Health is trading higher, reflecting positive market conditions, though no specific news was identified to explain the price movement.

24 lug 2026, 19:26 UTC

Elanco Animal Health shares are higher, reflecting broader market dynamics amid a pullback in crude oil prices and easing energy-related pressures.

23 lug 2026, 10:16 UTC

Elanco Animal Health is trading roughly flat in pre-market hours, despite broader market declines influenced by earnings reports and rising oil prices.

22 lug 2026, 19:25 UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21 lug 2026, 19:26 UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20 lug 2026, 19:46 UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Confronto tra pari

Modifica del prezzo

Elanco Animal Health Inc Previsione

Obiettivo di Prezzo

By TipRanks

28.3% in crescita

Previsioni per 12 mesi

Media 31.33 USD  28.3%

Alto 34 USD

Basso 26 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Elanco Animal Health Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

12 ratings

11

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

128 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
help-icon Live chat